AVXL Anavex Life Sciences
Anavex Life Sciences earnings company data as of 4:49 AM ET 10/23
- 1 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 24 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 25 Aug | EPS | -0.08 | -0.06 | Beat |
| Rev | — | — | — |
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.01,5.07 | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| 10-K/A | FORM 10-K/A | Filing Doc | |
| 10-Q/A | FORM 10-Q/A | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.